Full-Time

Project Manager / Senior Project Manager

Operations

Posted on 9/11/2026

BioAgilytix

BioAgilytix

501-1,000 employees

Global bioanalytical testing for drug development

No salary listed

Durham, NC, USA

In Person

Full-time in-office attendance is required.

Bachelor's, Master's

Category
Project & Program Management (1)
Required Skills
NetSuite
Microsoft Office
Data Visualization
Word/Pages/Docs
Quality Assurance (QA)
Excel/Numbers/Sheets
Microsoft Outlook

Get referred to BioAgilytix

See people who can refer or advise you

Requirements
  • A bachelor's degree in life science or a related field with at least 4 years of experience in biotechnology project management or a related field, or a master's degree in life science or a related field with at least 2 years of relevant experience for the Project Manager level.
  • A bachelor's degree in life science or a related field with at least 6 years of experience in biotechnology project management or a related field, or a master's degree in life science or a related field with at least 4 years of relevant experience for the Senior Project Manager level.
  • Scientific knowledge and familiarity with regulations relevant to the contract research organization industry.
  • Knowledge of project management software.
  • Effective written and verbal communication skills with the ability to interact successfully with clients and internal stakeholders.
  • Strong attention to detail with organizational and project administration skills.
  • Proficiency in Microsoft Office, including Word, Excel, and Outlook.
  • Excellent written and verbal communication skills with the ability to manage key client and internal stakeholder relationships.
  • Strong organizational and project administration capabilities with the ability to coordinate multiple projects and priorities under time constraints.
  • Ability to work independently with limited supervision and exercise sound judgment in complex project situations.
Responsibilities
  • Serve as a key point of coordination between clients and internal project stakeholders.
  • Build working relationships across Operations, Quality Control, Quality Assurance, Sample Management, and other supporting functions.
  • Coordinate project timelines, deliverables, milestones, and stakeholder activities.
  • Facilitate client and project team meetings, including agendas, meeting minutes, decisions, and action items.
  • Monitor revenue recognition and project milestones using financial systems.
  • Identify challenges that could impact successful program delivery and work cross-functionally to resolve them.
  • Support identification and execution of contract amendments in partnership with the Proposals team.
  • Use project management tools to organize work, increase visibility, and foster collaboration.
  • Adapt to changing project requirements while maintaining focus on client needs and program delivery.
  • Coordinate project elements and stakeholders to support successful delivery.
  • Manage intermediate-level project segments and associated deliverables.
  • Support routine client teleconferences and formalize decisions and actions through agendas and meeting minutes.
  • Monitor project activities and help address issues that could impact program delivery.
  • Apply project management tools and processes to improve task management and team collaboration.
  • Act as the client's internal advocate, driving cross-site communication, transparency, and alignment.
  • Lead higher-complexity and multiple concurrent projects from initiation through closeout.
  • Maintain alignment between project execution, strategic goals, budget, scope, and forecasted timelines.
  • Lead routine client teleconferences and drive decisions, actions, and follow-through.
  • Define and monitor project timelines with internal and external stakeholders.
  • Proactively identify project risks, barriers, and potential delivery issues and drive resolution through defined escalation pathways.
  • Proactively identify required contract amendments and coordinate them from identification through execution.
  • Support program-level dashboards and key performance indicators that provide visibility into project risk and governance.
  • Exercise significant independent judgment and discretionary authority in managing assigned programs.
Desired Qualifications
  • NetSuite experience.
  • Smartsheet experience.
  • Experience in biotechnology, pharmaceutical, contract research organization, contract manufacturing organization, or a similar industry.
  • Project Management Professional certification.

BioAgilytix is a global bioanalytical laboratory that provides testing services for pharmaceutical, biotechnology, and agricultural biotech companies, with a notable presence in Hamburg, Europe. It specializes in large-molecule studies and runs assays such as pharmacokinetics, pharmacodynamics, cell-based tests, and immunogenicity to measure how drugs behave in the body and assess safety and efficacy. The company offers customizable, service-based testing that supports drug development from research through regulatory approval, including COVID-19 testing packages. Its differentiators are its global reach, deep expertise in large-molecule workflows, and a flexible model that partners with clients on a project basis. Its goal is to deliver precise, validated bioanalytical data that helps clients develop and bring new therapies to market.

Company Size

501-1,000

Company Stage

Growth Equity (Venture Capital)

Total Funding

$30.1M

Headquarters

Durham, North Carolina

Founded

2008

Get referred to BioAgilytix

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Lexeo’s February 2026 gene-therapy program elevates BioAgilytix into premium regulatory work.
  • May 2026 Morrisville GMP expansion increases capacity for higher-margin QC testing.
  • Hamburg regained French CIR approval in 2026, supporting European commercial credibility.

What critics are saying

  • BioAgilytix sued ex-executive James McNally in April 2025 over trade secrets.
  • Revelio shows 2026 active postings fell 46.8%, signaling slower hiring momentum.
  • Heavy private-equity ownership from Cinven and Cobepa pressures margin expansion and exit timing.

What makes BioAgilytix unique

  • FDA granted BioAgilytix Breakthrough Device Designation for AAVrh.10 assay in February 2026.
  • BioAgilytix runs 355,000 square feet across Durham, Hamburg, and Australia.
  • Its 2025-2026 LC/MS investments strengthened global bioanalysis and CMC analytical services.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Sick Leave

Paid Holidays

401(k) Company Match

Parental Leave

Employee Referral Bonus

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

12%
BioAgilytix
Mar 24th, 2026
BioAgilytix celebrates Jessica Bridges Weaver for scientific leadership with 2026 TBJ Award.

BioAgilytix celebrates Jessica Bridges Weaver for scientific leadership with 2026 TBJ Award. Durham, N.C. - March 24, 2026 - BioAgilytix, a global leader in bioanalytical services, is proud to celebrate its commitment to scientific excellence and leadership with Jessica Bridges Weaver, Scientific Officer, who has been named a 2026 Triangle Business Journal Women in Business Award Winner. With more than 20 years of experience across pharmaceutical manufacturing and analytical testing, Jessica has played a critical role in strengthening BioAgilytix's scientific and regulatory leadership. In her role, she partners closely with global laboratory and business development teams to advise clients on phase-appropriate, regulatory-ready testing strategies for complex biologics. Her work extends to assay design and troubleshooting, ensuring methods align with both client objectives and evolving global regulatory expectations. Her impact has been especially evident in the strategic expansion of BioAgilytix's CMC analytical testing services in the Research Triangle Park hub, as well as the global growth of GMP bioassay capabilities and the development of specialized infrastructure in Hamburg, Germany. Beyond operational leadership, Jessica is a recognized thought leader in CMC analytics and bioanalysis who produces and delivers webinars, conference presentations, and peer-reviewed publications that promote continuous learning and knowledge-sharing across the life sciences community. "Jessica exemplifies the scientific rigor, integrity, and collaborative leadership that defines BioAgilytix," said Davide Molho, Chief Executive Officer of BioAgilytix. "Her ability to translate complex science into meaningful impact for our clients and the industry makes her an outstanding leader and a deserving recipient of this recognition." In addition to her professional achievements, Jessica is deeply committed to community service and mentorship. She actively supports STEM education initiatives, mentors high school students, and partners with organizations focused on pediatric care and child welfare. Her work reflects a lifelong commitment to stewardship, integrity, and expanding access to opportunities for future generations. "It is truly an honor to be recognized alongside so many inspiring women," said Jessica Weaver. "This recognition reflects the incredible teams I am privileged to work with at BioAgilytix and our shared commitment to advancing science, strengthening communities, and improving patients' lives. I am grateful for the opportunity to contribute to work that creates meaningful impact for our clients and the broader life sciences community." Jessica's recognition represents the strength of the BioAgilytix community, and a culture built on collaboration, integrity, and scientific excellence. About BioAgilytix BioAgilytix is the trusted partner for bioanalytical services throughout every phase of the drug development process. As a leading global bioanalytical laboratory, the company provides established and emerging pharmaceutical and biotechnology organizations with pharmacokinetic (PK), immunogenicity, biomarker, and CMC analytical testing services in a GxP environment. BioAgilytix maintains state-of-the-art laboratories in Durham, North Carolina; Boston, Massachusetts; San Diego, California; Melbourne and Brisbane, Australia; and Hamburg, Germany. For more information, please visit www.bioagilytix.com.

Associated Press
Feb 10th, 2026
BioAgilytix receives FDA breakthrough device designation for anti-AAV antibody assay supporting gene therapy

BioAgilytix Labs has received FDA Breakthrough Device Designation for its anti-AAV antibody assay supporting Lexeo Therapeutics' gene therapy programme for Friedreich ataxia cardiomyopathy, a rare progressive disorder affecting approximately 15,000 people worldwide. The plate-based MSD anti-adeno-associated virus serotype rh.10 total antibody assay enables precise patient selection and monitoring for gene therapy programmes. The FDA's Breakthrough Device Designation expedites development and review of novel medical devices treating life-threatening or irreversibly debilitating conditions. BioAgilytix is among a limited number of contract research organisations to receive breakthrough designation for a diagnostic assay supporting an investigational device exemption. The Durham, North Carolina-based company operates laboratories across the US, Australia and Germany, providing bioanalytical testing services for pharmaceutical and biotechnology organisations.

Rapid Test Methods Ltd
Jun 18th, 2024
BBI and BioAgilytix Partner to Streamline and Simplify Bioanalytical Testing

BBI Solutions OEM Limited (BBI), a trusted expert provider of end-to-end solutions for the development of high-performance assays, has signed a partnership agreement with BioAgilytix, a leading global bioanalytical laboratory.

The Business Journals
Mar 26th, 2024
Durham firm cancels deal that promised 878 jobs

BioAgilytix in 2020 picked the Triangle over competing sites in Massachusetts for a $61.5 million expansion that was expected to add 878 local jobs.

GenomeWeb
Sep 13th, 2023
A3P Biomedical, BioAgilytix Partner to Bring Prostate Cancer Test to US

NEW YORK - Swedish diagnostics firm A3P Biomedical announced on Wednesday that it has partnered with BioAgilytix to bring A3P's prostate cancer test to the US as a laboratory-developed test.